XWEL — XWELL Inc.
NASDAQ · Healthcare · Diagnostics & Research
$0.97
+$0.02 (+1.69%)
XWELL Inc. (XWEL) is a diagnostics & research company listed on NASDAQ. It is led by Ezra T. Ernst, based in 254 West 31st Street, New York, NY, United States, 10001, with about 175 employees. XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program; and various services and support, including technical support services and advanced services. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
Latest reported XWEL revenue for 2025-09-30 was $7.3M. Net income was -$211.0K. Revenue was down 4.5% from 2025-06-30 to 2025-09-30. XWEL currently screens at market cap $10.4M.
Use this XWEL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XWEL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XWEL SEC filings page. Lician reads the product cache first so this HTML stays unique to XWELL Inc. even when a live quote feed is slow.
About XWELL Inc.
XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program; and various services and support, including technical support services and advanced services. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
XWEL Key Statistics
Market Cap
$10.39M
Volume
157,766
Previous Close
$1.01
Day Range
$0.96 – $1.17
P/B Ratio
26.70
EPS
-$3.66
Revenue
$33.90M
Net Income
-$16.49M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+12.6%
Profit Margin
-48.6%
Employees
175
XWEL Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $33.90M | $30.11M | $55.94M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$16.49M | -$28.03M | -$32.63M |
| EPS (Diluted) | -$3.66 | -$6.64 | -$7.01 |
Total Assets
$25.35M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$4.55M
Operating Cash Flow
-$11.01M
Free Cash Flow
$0.00
XWELL Inc. Company Information
- President, CEO & Director
- Ezra T. Ernst
- Headquarters
- 254 West 31st Street, New York, NY, United States, 10001
- Website
- www.xwell.com
- Phone
- 212 750 9595
- IPO / Founded
- 2018-01-05
- Sector
- Healthcare
- Industry
- Diagnostics & Research